Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA(IMP) 3473 |
|---|---|
| 2: Name of authorisation holder | NHS NATIONAL SERVICES SCOTLAND |
| 3: Address(es) of manufacturing site(s) |
NHS NATIONAL SERVICES SCOTLAND, THE JACK COPLAND CENTRE, 52 RESEARCH AVENUE NORTH, HERIOT-WATT RESEARCH PARK, RICCARTON, CURRIE, EH14 4BE, UNITED KINGDOM SCOTTISH CENTRE FOR REGENERATIVE MEDICINE, GMP CELLULAR THERAPY FACILITY, SCOTTISH CENTRE FOR REGENERATIVE MEDICINE, EDINBURGH BIOQUARTER, 5 LITTLE FRANCE DRIVE, EDINBURGH, EH16 4UU, UNITED KINGDOM |
| 4: Legally registered address of authorisation holder | NHS NATIONAL SERVICES SCOTLAND, THE JACK COPLAND CENTRE, 52 RESEARCH AVENUE NORTH, HERIOT-WATT RESEARCH PARK, RICCARTON, CURRIE, EH14 4BE, UNITED KINGDOM |
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
| 8: Authorisation Date | 06/12/2023 |
| 9: Annexes attached | Annex 1 and/or Annex 2 |
NHS NATIONAL SERVICES SCOTLAND, THE JACK COPLAND CENTRE, 52 RESEARCH AVENUE NORTH, HERIOT-WATT RESEARCH PARK, RICCARTON, CURRIE, EH14 4BE, UNITED KINGDOM
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.1 ] Sterile Investigational Medicinal Products |
| [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) |
| [ 1.1.1.6 ] Other aseptically prepared products Human derived ATMPs as stipulated in 1394/2007. Cell banking of cells of human origin. Should be authorised. |
| [ 1.3 ] Biological investigational medicinal products |
| [ 1.3.1 ] Biological medicinal products |
| [ 1.3.1.3 ] Cell therapy products |
| [ 1.3.1.8 ] Other biological medicinal products Human derived ATMPs as stipulated in 1394/2007. Cell banking of cells of human origin. |
| [ 1.5 ] Packaging |
| [ 1.5.1 ] Primary packaging |
| [ 1.5.1.6 ] Liquids for internal use |
| [ 1.5.2 ] Secondary packaging |
| [ 1.6 ] Quality control testing |
| [ 1.6.2 ] Microbiological: non-sterility |
| [ 1.6.3 ] Chemical/Physical |
| [ 1.6.4 ] Biological |
SCOTTISH CENTRE FOR REGENERATIVE MEDICINE, GMP CELLULAR THERAPY FACILITY, SCOTTISH CENTRE FOR REGENERATIVE MEDICINE, EDINBURGH BIOQUARTER, 5 LITTLE FRANCE DRIVE, EDINBURGH, EH16 4UU, UNITED KINGDOM
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.1 ] Sterile Investigational Medicinal Products |
| [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) |
| [ 1.1.1.6 ] Other aseptically prepared products Human derived ATMPS as stipulated in 1394/2007 |
| [ 1.3 ] Biological investigational medicinal products |
| [ 1.3.1 ] Biological medicinal products |
| [ 1.3.1.3 ] Cell therapy products |
| [ 1.3.1.6 ] Human or animal extracted products |
| [ 1.3.1.8 ] Other biological medicinal products Cell banking of cells of human origin |
| [ 1.5 ] Packaging |
| [ 1.5.1 ] Primary packaging |
| [ 1.5.1.6 ] Liquids for internal use |
| [ 1.5.2 ] Secondary packaging |
| [ 1.6 ] Quality control testing |
| [ 1.6.2 ] Microbiological: non-sterility |
| [ 1.6.3 ] Chemical/Physical |
| [ 1.6.4 ] Biological |